Triple
T22889006
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CYP2C19 |
E567681
|
entity |
| Predicate | metabolizes |
P37221
|
FINISHED |
| Object | citalopram |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: citalopram | Statement: [CYP2C19, metabolizes, citalopram]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: citalopram Context triple: [CYP2C19, metabolizes, citalopram]
-
A.
Zoloft
Zoloft is a widely prescribed antidepressant medication (sertraline) in the selective serotonin reuptake inhibitor (SSRI) class, commonly used to treat depression, anxiety disorders, and related conditions.
-
B.
Prozac
Prozac is a widely prescribed antidepressant medication (fluoxetine) used to treat major depressive disorder, anxiety disorders, and certain other mental health conditions.
-
C.
Cymbalta
Cymbalta is a prescription antidepressant medication (duloxetine) commonly used to treat major depressive disorder, generalized anxiety disorder, and certain types of chronic pain.
-
D.
amitriptyline
Amitriptyline is a tricyclic antidepressant primarily used to treat major depressive disorder, neuropathic pain, and migraine prophylaxis.
-
E.
SSRI
An SSRI (selective serotonin reuptake inhibitor) is a class of antidepressant medications that increase serotonin levels in the brain to treat conditions like depression and anxiety disorders.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: citalopram Target entity description: Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant commonly prescribed to treat major depressive disorder and related mood conditions.
-
A.
Zoloft
Zoloft is a widely prescribed antidepressant medication (sertraline) in the selective serotonin reuptake inhibitor (SSRI) class, commonly used to treat depression, anxiety disorders, and related conditions.
-
B.
Prozac
Prozac is a widely prescribed antidepressant medication (fluoxetine) used to treat major depressive disorder, anxiety disorders, and certain other mental health conditions.
-
C.
Cymbalta
Cymbalta is a prescription antidepressant medication (duloxetine) commonly used to treat major depressive disorder, generalized anxiety disorder, and certain types of chronic pain.
-
D.
amitriptyline
Amitriptyline is a tricyclic antidepressant primarily used to treat major depressive disorder, neuropathic pain, and migraine prophylaxis.
-
E.
SSRI
An SSRI (selective serotonin reuptake inhibitor) is a class of antidepressant medications that increase serotonin levels in the brain to treat conditions like depression and anxiety disorders.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2458a92ec81908fc1cd5f6407d2ab |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17fc37a448190996e106aacc900f4 |
completed | April 29, 2026, 3:49 a.m. |
Created at: April 17, 2026, 3:40 p.m.